Institutional members access full text with Ovid®

Managing acute bacterial skin and skin structure infections: Focus on new lipoglycopeptides

Bell, Allison M. PharmD; King, S. Travis PharmD; Barber, Katie E. PharmD; Adcock, Kim G. PharmD; Wagner, Jamie L. PharmD; Stover, Kayla R. PharmD

doi: 10.1097/01.NPR.0000515428.68779.87
Online exclusive

Abstract: Acute bacterial skin and skin structure infections (ABSSSI) are some of the most commonly encountered infections worldwide. Hospitalizations as a result of ABSSSI are associated with high mortality. This article discusses the role of oritavancin and dalbavancin, two new lipoglycopeptides, in the context of the other I.V. available standard therapy options.

Allison M. Bell is an assistant professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss.

S. Travis King is an assistant professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss.

Katie E. Barber is an assistant professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss.

Kim G. Adcock is a professor in the Department of Pediatrics at the University of Mississippi Medical Center, Jackson, Miss., and a professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss.

Jamie L. Wagner is a clinical assistant professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss.

Kayla R. Stover is an associate professor in the Department of Pharmacy Practice at the University of Mississippi School of Pharmacy, Jackson, Miss.

The authors have disclosed that they have no financial relationships related to this article.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.